DJIA 18,037.97 -42.17 -0.23%
NASDAQ 5,060.25 -31.84 -0.63%
S&P 500 2,108.92 -8.77 -0.41%
market minute promo


256.82 0.23 (0.09%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PCYC $256.82 0.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $256.99
Previous Close $256.59
Daily Range $256.30 - $257.49
52-Week Range $82.51 - $260.47
Market Cap $19.7B
P/E Ratio 233.26
Dividend (Yield) $0.00 (0.0%)
Volume 618,158
Average Daily Volume 963,418
Current FY EPS $0.26




Drug Makers


A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases. Website:

News & Commentary

Humira Propels AbbVie Inc. to a Solid First Quarter

AbbVie beats expectations on the strength of Humira, with help from new hep C drug Viekira Pak.

AbbVie Focusing On Diversification Routes To Put Higher Sales Numbers On The Board

AbbVie Beats Earnings on Humira and HCV Sales, Ups View - Analyst Blog

Notable ETF Inflow Detected - FBT, ICPT, PCYC, CLDX

Gilead Sciences Vs. AbbVie: Which Is A Better Buy?

Pharmacyclics Announces Positive Results on Imbruvica - Analyst Blog

Is AbbVie (ABBV) Set to Top 1Q Earnings on Humira & HCV? - Analyst Blog

Pharmacyclics Shares Fall As Kyle Bass Files Petition To Cancel Patent

Johnson & Johnson's Earnings: What You Need to Know

Here’s what Johnson & Johnson’s quarterly earnings call means to investors like you.

Johnson & Johnson's Earnings: The Good, The Bad and The Ugly

Johnson & Johnson reported a mixed first-quarter this week. Here is what investors need to know going forward.

See More PCYC News...

PCYC's Top Competitors

PCYC $256.82 (0.09%)
Current stock: PCYC
AMGN $162.38 (-3.29%)
Current stock: AMGN
GILD $102.94 (-0.73%)
Current stock: GILD
BIIB $389.27 (-3.10%)
Current stock: BIIB